Trials / Completed
CompletedNCT03471039
PACAP27 Headache Properties in Migraine Without Aura Patients
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP27) Headache Properties in Migraine Without Aura Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a signaling molecule, localized in sensory and parasympathetic perivascular nerves fibres. PACAP exists i to functional iso-forms Pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and PACAP27.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PACAP27 | Infusion of PACAP27 over 20 minutes. |
| DRUG | Saline | Infusion of Saline over 20 minutes. |
Timeline
- Start date
- 2017-08-30
- Primary completion
- 2018-08-30
- Completion
- 2018-09-30
- First posted
- 2018-03-20
- Last updated
- 2019-01-24
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03471039. Inclusion in this directory is not an endorsement.